Non-viral vectors are promising vehicles for gene therapy but delivery of plasmid DNA to post-mitotic cells is challenging as nuclear entry is particularly inefficient. We have developed and evaluated a hybrid mRNA/DNA system designed to bypass the nuclear barrier to transfection and facilitate cytoplasmic gene expression. This system, based on co-delivery of mRNA(A64) encoding for T7 RNA polymerase (T7 RNAP) with a T7-driven plasmid, produced between 10- and 2200-fold higher gene expression in primary dorsal root ganglion neuronal (DRGN) cultures isolated from Sprague–Dawley rats compared to a cytomegalovirus (CMV)-driven plasmid, and 30-fold greater expression than the enhanced T7-based autogene plasmid pR011. Cell-free assays and in vitr...
Abstract Background Chemical methods of transfection that have proven successful with cell lines oft...
Non-viral gene therapy vectors have not yet achieved the gene transfer efficiency of viral vectors b...
Delivering gene constructs into the dorsal root ganglia (DRG) is a powerful but challenging therapeu...
Non-viral vectors are promising vehicles for gene therapy but delivery of plasmid DNA to post-mitoti...
The relatively low levels of transfection that can be achieved by current gene delivery systems have...
A novel cytoplasmic gene expression system has been developed. This system differs from other expres...
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucle...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
Cell reprogramming requires efficient delivery of reprogramming transcription factors into the cell ...
Synthetic vectors based on reducible polycations consisting of histidine and polylysine residues (HI...
Non-viral gene delivery vectors with messenger RNA (mRNA) as a carrier of genetic information are am...
This is the first demonstration of receptor-mediated delivery of mRNA and establishes a new approach...
International audienceBackground: Gene delivery within the central nervous system at postnatal age i...
Abstract Background Chemical methods of transfection that have proven successful with cell lines oft...
Non-viral gene therapy vectors have not yet achieved the gene transfer efficiency of viral vectors b...
Delivering gene constructs into the dorsal root ganglia (DRG) is a powerful but challenging therapeu...
Non-viral vectors are promising vehicles for gene therapy but delivery of plasmid DNA to post-mitoti...
The relatively low levels of transfection that can be achieved by current gene delivery systems have...
A novel cytoplasmic gene expression system has been developed. This system differs from other expres...
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucle...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs...
Cell reprogramming requires efficient delivery of reprogramming transcription factors into the cell ...
Synthetic vectors based on reducible polycations consisting of histidine and polylysine residues (HI...
Non-viral gene delivery vectors with messenger RNA (mRNA) as a carrier of genetic information are am...
This is the first demonstration of receptor-mediated delivery of mRNA and establishes a new approach...
International audienceBackground: Gene delivery within the central nervous system at postnatal age i...
Abstract Background Chemical methods of transfection that have proven successful with cell lines oft...
Non-viral gene therapy vectors have not yet achieved the gene transfer efficiency of viral vectors b...
Delivering gene constructs into the dorsal root ganglia (DRG) is a powerful but challenging therapeu...